Skip to main content

Breast Cancer Research and Treatment

Ausgabe 3/2010

Inhalt (31 Artikel)

Preclinical study

Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells

Shih-Hsin Tu, Chih-Chiang Chang, Ching-Shyang Chen, Ka-Wai Tam, Ying-Jan Wang, Chia-Hwa Lee, Hsiao-Wei Lin, Tzu-Chun Cheng, Ching-Shui Huang, Jan-Show Chu, Neng-Yao Shih, Li-Ching Chen, Sy-Jye Leu, Yuan-Soon Ho, Chih-Hsiung Wu

Preclinical study

Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma

Mohamed Kamal, Abeer M. Shaaban, Liqun Zhang, Clare Walker, Sally Gray, Nalin Thakker, Carmel Toomes, Valerie Speirs, Sandra M. Bell

Preclinical study

A prospective study of variability in mammographic density during the menstrual cycle

Monica Morrow, Robert T. Chatterton Jr., Alfred W. Rademaker, Nanjiang Hou, V. Craig Jordan, R. Edward Hendrick, Seema A. Khan

Preclinical study

An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers

Rachael Natrajan, Britta Weigelt, Alan Mackay, Felipe C. Geyer, Anita Grigoriadis, David S. P. Tan, Chris Jones, Christopher J. Lord, Radost Vatcheva, Socorro M. Rodriguez-Pinilla, Jose Palacios, Alan Ashworth, Jorge S. Reis-Filho

Preclinical study

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

Yanlin Sun, Tingguo Zhang, Peng Gao, Bin Meng, Yongsheng Gao, Xiao Wang, Jianping Zhang, Hao Wang, Xiaojuan Wu, Wenxin Zheng, Gengyin Zhou

Preclinical study

Breast cancer cells can switch between estrogen receptor α and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance

Katrine Sonne-Hansen, Ida C. Norrie, Kristina B. Emdal, Rikke V. Benjaminsen, Thomas Frogne, Ib J. Christiansen, Tove Kirkegaard, Anne E. Lykkesfeldt

Clinical trial

High levels of uPA and PAI-1 predict a good response to anthracyclines

Simona Borstnar, Aleksander Sadikov, Barbara Mozina, Tanja Cufer

Clinical trial

Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications

Didier Cowen, E. Gross, P. Rouannet, E. Teissier, S. Ellis, M. Resbeut, A. Tallet, V. Vaini Cowen, D. Azria, J. M. Hannoun-Levi

Epidemiology

Metabolic profile, physical activity, and mortality in breast cancer patients

Aina Emaus, Marit Bragelien Veierød, Steinar Tretli, Sissi Espetvedt Finstad, Randi Selmer, Anne-Sofie Furberg, Leslie Bernstein, Ellen Schlichting, Inger Thune

Epidemiology

Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest

Dana E. Rollison, Anna R. Giuliano, Betsy C. Risendal, Carol Sweeney, David Boulware, Christine Laronga, Kathy B. Baumgartner, Tim Byers, Martha L. Slattery

Epidemiology

Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region

Jenny Chia-Yun Wu, Ahti Anttila, Amy Ming-Fang Yen, Matti Hakama, Irma Saarenmaa, Tytti Sarkeala, Nea Malila, Anssi Auvinen, Sherry Yueh-Hsia Chiu, Tony Hsiu-Hsi Chen

Epidemiology

Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years

Mats Lambe, Annette Wigertz, Marit Holmqvist, Jan Adolfsson, Carola Bardage, Tommy Fornander, Per Karlsson, Viveca Odlind, Ingemar Persson, Johan Ahlgren, Leif Bergkvist

Epidemiology

Gene promoter methylation is associated with increased mortality among women with breast cancer

Xinran Xu, Marilie D. Gammon, Yujing Zhang, Yoon Hee Cho, James G. Wetmur, Patrick T. Bradshaw, Gail Garbowski, Hanina Hibshoosh, Susan L. Teitelbaum, Alfred I. Neugut, Regina M. Santella, Jia Chen

Epidemiology

A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk

Rongxi Yang, Bettina Schlehe, Kari Hemminki, Christian Sutter, Peter Bugert, Barbara Wappenschmidt, Juliane Volkmann, Raymonda Varon, Bernhard H. F. Weber, Dieter Niederacher, Norbert Arnold, Alfons Meindl, Claus R. Bartram, Rita K. Schmutzler, Barbara Burwinkel

Epidemiology

Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects

Li-Xin Qiu, Hui Yuan, Ke-Da Yu, Chen Mao, Bo Chen, Ping Zhan, Kai Xue, Jian Zhang, Xi-Chun Hu

Epidemiology

Impact of multiple caregiving roles on elevated depressed mood in early-stage breast cancer patients and same-age controls

Ellen H. Bailey, Maria Pérez, Rebecca L. Aft, Ying Liu, Mario Schootman, Donna B. Jeffe

Epidemiology

Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics

Jonine D. Figueroa, Kathleen C. Flanders, Montserrat Garcia-Closas, William F. Anderson, Xiaohong R. Yang, Rayna K. Matsuno, Máire A. Duggan, Ruth M. Pfeiffer, Akira Ooshima, Robert Cornelison, Gretchen L. Gierach, Louise A. Brinton, Jolanta Lissowska, Beata Peplonska, Lalage M. Wakefield, Mark E. Sherman

Epidemiology

Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer

Sujee Jeon, Ji-Yeob Choi, Kyoung-Mu Lee, Sue K. Park, Keun-Young Yoo, Dong-Young Noh, Sei-Hyun Ahn, Daehee Kang

Epidemiology

Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women

Elena M. Kouri, Yulei He, Eric P. Winer, Nancy L. Keating

Brief Report

Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model

Michele L. Martin, Erika M. Wall, Emily Sandwith, Adam Girardin, Katy Milne, Peter H. Watson, Brad H. Nelson

Brief Report

Two-stage case–control study of DNMT-1 and DNMT-3B gene variants and breast cancer risk

Chuanzhong Ye, Alicia Beeghly-Fadiel, Wei Lu, Jirong Long, Xiao Ou Shu, Yu-Tang Gao, Wei Zheng, Qiuyin Cai

Brief Report

Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy

Hee Sung Kim, Cha Kyong Yom, Hee Jeong Kim, Jong Won Lee, Jin Hee Sohn, Jun Ho Kim, Yong Lai Park, Sei Hyun Ahn

Brief Report

Severe prolonged cholestatic hepatitis caused by exemestane

Ting Bao, John Fetting, Laura Mumford, Jane Zorzi, Karineh Shahverdi, Stacie Jeter, Frank Herlong, Vered Stearns, Linda Lee

Letter to the Editor

Tamoxifen sensitivity and estrogen receptor mRNA levels

P. N. Span, H. W. van Laarhoven, F. C. G. J. Sweep

Letter to the Editor

Sustained lower rates of breast cancer incidence in France in 2007

Brigitte Séradour, Hubert Allemand, Alain Weill, Philippe Ricordeau

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.